UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 19, 2014

THE CLOROX COMPANY
(Exact name of registrant as specified in its charter)

___________________
 

Delaware 1-07151 31-0595760
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer
incorporation) Identification No.)

1221 Broadway, Oakland, California 94612-1888
(Address of principal executive offices)  (Zip code)

(510) 271-7000
(Registrant's telephone number, including area code)

Not applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

On November 19, 2014, The Clorox Company (the “Company”) held its annual meeting of stockholders in Pleasanton, California. The matters voted on and the results of the vote were as follows:

      1.      The Company’s stockholders elected the following directors to each serve until the next Annual Meeting of Stockholders or until a successor is duly elected and qualified.

      Number of Votes
For       Against       Abstain       Broker Non-Votes
Daniel Boggan, Jr. 82,228,005 895,099 457,977 27,534,230
Richard H. Carmona 80,806,752 2,238,123 536,206 27,534,230
Benno Dorer 82,728,504 398,592 453,985 27,534,230
George J. Harad 81,038,613 2,068,554 473,914 27,534,230
Donald R. Knauss 82,425,049 700,291 455,741 27,534,230
Esther Lee 82,669,200 446,709 465,172 27,534,230
Robert W. Matschullat 80,603,442 2,516,183 461,456 27,534,230
Jeffrey Noddle 81,011,249 2,011,695 558,137 27,534,230
Rogelio Rebolledo 82,551,211 532,617 497,253 27,534,230
Pamela Thomas-Graham 82,726,338 405,751 448,992 27,534,230
Carolyn M. Ticknor 82,411,319 635,516 534,246 27,534,230

      2.      The Company’s stockholders voted for (on an advisory basis) the compensation of the Company’s named executive officers.

Number of Votes
For       Against       Abstain       Broker Non-Votes
76,781,099 5,720,566 1,079,416   27,534,230

      3.      The Company’s stockholders ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2015.

Number of Votes
For       Against       Abstain       Broker Non-Votes
109,654,070 789,527 671,714   0



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

THE CLOROX COMPANY
 
 
Date:  November 20, 2014 By:   /s/ Laura Stein
Senior Vice President – General Counsel